Digital Content 
NEWS #PharmaBuzz
07 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bergenbio-announces-new-preclinical-data-indicating-broadened-potential-for-bemcentinib-to-treat-severe-respiratory-infections-302055930.html
16 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/additional-data-on-bergenbios-selective-axl-inhibitor-bemcentinib-to-be-presented-at-the-2023-esmo-meeting-301957048.html
22 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bergenbio-announces-clinical-data-presentations-highlighting-the-activity-of-its-selective-axl-inhibitor-bemcentinib-in-non-small-cell-lung-cancer-301906548.html
09 Mar 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bergenbio-announces-first-patient-dosed-in-phase-1b2a-trial-evaluating-bemcentinib-in-1st-line-non-small-cell-lung-cancer-with-stk11-mutations-301767796.html
28 Sep 2022
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/bergenbio-covid-treatment-study/
27 Jan 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/bergenbio-and-oslo-university-hospital-announce-the-axl-inhibitor-bemcentinib-will-be-studied-in-the-eu-funded-eu-solidact-trial-in-hospitalised-covid-19-patients-301469371.html
LOOKING FOR A SUPPLIER?
Share